BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35019770)

  • 1. A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Gooden E; Brown DH; Eskander A; Zahedi A; Chung J; Su J; Xu W; Ihekire O; Jones JM; Gafni A; Baxter NN; Goldstein DP;
    Thyroid; 2022 Mar; 32(3):255-262. PubMed ID: 35019770
    [No Abstract]   [Full Text] [Related]  

  • 2. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
    Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
    Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
    [No Abstract]   [Full Text] [Related]  

  • 3. Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Zahedi A; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP
    Thyroid; 2024 May; 34(5):626-634. PubMed ID: 38481111
    [No Abstract]   [Full Text] [Related]  

  • 4. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
    Sawka AM; Ghai S; Tomlinson G; Baxter NN; Corsten M; Imran SA; Bissada E; Lebouef R; Audet N; Brassard M; Zhang H; Gupta M; Nichols AC; Morrison D; Johnson-Obeski S; Prisman E; Anderson D; Chandarana SP; Ghaznavi S; Jones J; Gafni A; Matelski JJ; Xu W; Goldstein DP;
    Front Endocrinol (Lausanne); 2021; 12():686996. PubMed ID: 34194396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Differences in Fears Related to Low-Risk Papillary Thyroid Cancer and Its Treatment.
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Zahedi A; Gooden E; Eskander A; Chung J; Devon K; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP;
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):803-810. PubMed ID: 37410454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
    Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
    Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
    Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
    J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.
    Issa PP; Munshi R; Albuck AL; Omar M; Abu Alhuda RF; Metz T; Hussein M; Shama M; Lee GS; Toraih E; Kandil E
    Am J Otolaryngol; 2023; 44(6):103994. PubMed ID: 37607459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro).
    Hwangbo Y; Choi JY; Lee EK; Ryu CH; Cho SW; Chung EJ; Hah JH; Jeong WJ; Park SK; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee JY; Lee YJ; Yu HW; Park DJ; Ryu J; Park YJ; Lee KE; Moon JH
    Thyroid; 2022 Jul; 32(7):772-780. PubMed ID: 35698288
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery.
    Yoshida Y; Horiuchi K; Okamoto T
    Thyroid; 2020 May; 30(5):681-687. PubMed ID: 31910100
    [No Abstract]   [Full Text] [Related]  

  • 11. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer.
    Sawka AM; Ghai S; Tomlinson G; Rotstein L; Gilbert R; Gullane P; Pasternak J; Brown D; de Almeida J; Irish J; Chepeha D; Higgins K; Monteiro E; Jones JM; Gafni A; Goldstein DP
    BMJ Open; 2018 Apr; 8(4):e020298. PubMed ID: 29654030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.
    Pitt SC; Saucke MC; Wendt EM; Schneider DF; Orne J; Macdonald CL; Connor NP; Sippel RS
    Thyroid; 2021 Apr; 31(4):580-588. PubMed ID: 33012267
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
    DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
    BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
    Griffin A; Brito JP; Bahl M; Hoang JK
    Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
    Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
    JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    McDow AD; Roman BR; Saucke MC; Jensen CB; Zaborek N; Jennings JL; Davies L; Brito JP; Pitt SC
    Am J Surg; 2021 Jul; 222(1):111-118. PubMed ID: 33248684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America.
    Smulever A; Pitoia F
    Arch Endocrinol Metab; 2019; 63(5):462-469. PubMed ID: 31482955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
    Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
    J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.